Evidence map›Paper›PMID 29617597›Full record

ArticleAmerican journal of public health2018

Drug Purchasing Strategies to Treat People With Hepatitis C in the Criminal Justice System.

Matthew J Akiyama, Rich Feffer, William H von Oehsen, Alain H Litwin

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. "You can get a couple of ramen noodle packs for a BusparResearch in social & administrative pharmacy : RSAP · 2023
    Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matthew J AkiyamaMatthew J. Akiyama is with the Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY. Rich Feffer is with Hepatitis Education Project, Seattle, WA. William H. von Oehsen III is with Powers Pyle Sutter & Verville PC, Washington, DC. Alain H. Litwin is with the Department of Medicine, Greenville Health System, Greenville, SC; University of South Carolina School of Medicine, Greenville; and Clemson University School of Health Research, Clemson, SC.
Rich FefferMatthew J. Akiyama is with the Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY. Rich Feffer is with Hepatitis Education Project, Seattle, WA. William H. von Oehsen III is with Powers Pyle Sutter & Verville PC, Washington, DC. Alain H. Litwin is with the Department of Medicine, Greenville Health System, Greenville, SC; University of South Carolina School of Medicine, Greenville; and Clemson University School of Health Research, Clemson, SC.
William H von OehsenMatthew J. Akiyama is with the Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY. Rich Feffer is with Hepatitis Education Project, Seattle, WA. William H. von Oehsen III is with Powers Pyle Sutter & Verville PC, Washington, DC. Alain H. Litwin is with the Department of Medicine, Greenville Health System, Greenville, SC; University of South Carolina School of Medicine, Greenville; and Clemson University School of Health Research, Clemson, SC.
Alain H LitwinMatthew J. Akiyama is with the Department of Medicine, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY. Rich Feffer is with Hepatitis Education Project, Seattle, WA. William H. von Oehsen III is with Powers Pyle Sutter & Verville PC, Washington, DC. Alain H. Litwin is with the Department of Medicine, Greenville Health System, Greenville, SC; University of South Carolina School of Medicine, Greenville; and Clemson University School of Health Research, Clemson, SC.

Funding

Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants Living with Hepatitis C-The HCV-ACCELERATE TrialK99DA043011 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI AKIYAMA, MATTHEW · 2017 to 2018
$369k
NIDA NIH HHS K99 DA043011
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsHepatitis CCriminal LawHealth Services AccessibilityHumansPrisonsAntiviral Agents

Identifiers

PMID29617597
PMCPMC5888063

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.